NutriBand (NTRB) Net Cash Flow Growth (3y) (2019 - 2026)
NutriBand (NTRB) Net Cash Flow Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
NutriBand |
41.91 Mn |
37.33 Mn |
88,941.00 |
3.90% |
| Date | Value |
|---|
| Jan 31, 2026 |
3.90% |
| Oct 31, 2025 |
-47.14% |
| Jul 31, 2025 |
100.43% |
| Apr 30, 2025 |
-15.21% |
| Jan 31, 2025 |
-32.69% |
| Oct 31, 2024 |
-30.16% |
| Jul 31, 2024 |
-146.12% |
| Apr 30, 2024 |
211.95% |
| Jan 31, 2024 |
-165.22% |
| Oct 31, 2023 |
-142.55% |
| Jul 31, 2023 |
284.37% |
| Apr 30, 2023 |
-311.35% |
| Jan 31, 2023 |
-111.93% |
| Oct 31, 2022 |
-102.60% |
| Jul 31, 2022 |
-40.92% |
| Apr 30, 2022 |
-47.87% |
| Jan 31, 2022 |
-67.90% |
| Oct 31, 2021 |
101.41% |
| Jul 31, 2021 |
-27.99% |
| Jan 31, 2021 |
-302.90% |
